88020634 - EARLI

Information

  • Trademark
  • 88020634
  • Serial Number
    88020634
  • Registration Number
    7000700
  • Filing Date
    June 29, 2018
    7 years ago
  • Registration Date
    March 14, 2023
    2 years ago
  • Transaction Date
    September 20, 2023
    2 years ago
  • Status Date
    March 14, 2023
    2 years ago
  • Published for Opposition Date
    January 14, 2020
    5 years ago
  • Location Date
    February 09, 2023
    2 years ago
  • First Use Anywhere Date
    January 18, 2023
    2 years ago
  • First Use In Commerce Date
    January 18, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEE, DOUGLAS M
  • Attorney Docket Number
    34601-00070
    Attorney Name
    Connie L. Ellerbach
    Law Office Assigned Location Code
    O20
  • Owners
Mark Drawing Code
4000
Mark Identification
EARLI
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases
  • GS0011: Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use
Case File Event Statements
  • 3/14/2023 - 2 years ago
    51 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 3/14/2023 - 2 years ago
    50 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/10/2023 - 2 years ago
    49 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 2/9/2023 - 2 years ago
    48 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 2/2/2023 - 2 years ago
    47 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/31/2023 - 2 years ago
    46 - USE AMENDMENT FILED Type: IUAF
  • 1/31/2023 - 2 years ago
    45 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/18/2023 - 2 years ago
    44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/17/2023 - 2 years ago
    43 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 12/15/2022 - 2 years ago
    42 - SOU EXTENSION 5 FILED Type: EXT5
  • 1/4/2023 - 2 years ago
    41 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/15/2022 - 2 years ago
    40 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/16/2022 - 3 years ago
    39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/14/2022 - 3 years ago
    38 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 6/14/2022 - 3 years ago
    37 - SOU EXTENSION 4 FILED Type: EXT4
  • 6/14/2022 - 3 years ago
    36 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/18/2021 - 3 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/16/2021 - 3 years ago
    34 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/16/2021 - 3 years ago
    33 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/16/2021 - 3 years ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/18/2021 - 4 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/14/2021 - 4 years ago
    30 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/14/2021 - 4 years ago
    29 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/14/2021 - 4 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/24/2020 - 4 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/22/2020 - 4 years ago
    26 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/22/2020 - 4 years ago
    25 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/22/2020 - 4 years ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/14/2020 - 5 years ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/4/2020 - 5 years ago
    22 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 2/13/2020 - 5 years ago
    21 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/14/2020 - 5 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/14/2020 - 5 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/25/2019 - 5 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/11/2019 - 5 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 12/9/2019 - 5 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/20/2019 - 5 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/19/2019 - 5 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/19/2019 - 5 years ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 5/20/2019 - 6 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 5/20/2019 - 6 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/20/2019 - 6 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/30/2019 - 6 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/29/2019 - 6 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/29/2019 - 6 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/29/2018 - 7 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/29/2018 - 7 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/29/2018 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/22/2018 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/5/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/3/2018 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP